ce-326,597
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00542009)
Timeline
Indications
Studied for
Mechanism of action
- CholecystokininINHIBITOR
CCK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ce-326,597
- ce-326,597
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00576589 | Phase 1 | Jan 1, 2008 | Pfizer |
| NCT00542009 | Phase 2 | Dec 1, 2007 | Pfizer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 2 | 2 | 2 | 2007 |
1 organizations
Page 1 / 1